These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16936982)

  • 41. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children.
    Kirk JM; Mort C; Grant DB; Touzel RJ; Plowman N
    Med Pediatr Oncol; 1992; 20(3):201-8. PubMed ID: 1574029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.
    Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG
    Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preablative serum thyroglobulin as predictor of disease-free survival in differentiated thyroid cancer].
    Díaz RE; Véliz J; Wohllk N
    Rev Med Chil; 2013 Dec; 141(12):1506-11. PubMed ID: 24728426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma.
    Hoe FM; Charron M; Moshang T
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):25-30. PubMed ID: 16509525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyroglobulin in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E
    Scand J Clin Lab Invest Suppl; 1991; 206():79-84. PubMed ID: 1947763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
    Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
    Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 49. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.
    Fatima N; uz Zaman M; Ikram M; Akhtar J; Islam N; Masood Q; Zaman U; Zaman A
    Asian Pac J Cancer Prev; 2014; 15(15):6443-7. PubMed ID: 25124640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.
    Werner RA; Lückerath K; Schmid JS; Higuchi T; Kreissl MC; Grelle I; Reiners C; Buck AK; Lapa C
    Sci Rep; 2016 Jun; 6():28081. PubMed ID: 27306607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma.
    Frank RW; Middleton L; Stack BC; Spencer HJ; Riggs AT; Bodenner DL
    Head Neck; 2014 Feb; 36(2):155-7. PubMed ID: 23728951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study.
    Bellantone R; Lombardi CP; Bossola M; Ferrante A; Princi P; Boscherini M; Maussier L; Salvatori M; Rufini V; Reale F; Romano L; Tallini G; Zelano G; Pontecorvi A
    Cancer; 2001 Nov; 92(9):2273-9. PubMed ID: 11745281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low-to-intermediate risk differentiated thyroid carcinomas.
    Trimboli P; Zilioli V; Imperiali M; Ceriani L; Giovanella L
    Eur J Endocrinol; 2017 May; 176(5):497-504. PubMed ID: 28137736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.
    Malandrino P; Latina A; Marescalco S; Spadaro A; Regalbuto C; Fulco RA; Scollo C; Vigneri R; Pellegriti G
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1703-9. PubMed ID: 21450986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?
    Ibrahimpasic T; Ghossein R; Carlson DL; Nixon IJ; Palmer FL; Patel SG; Tuttle RM; Shaha A; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4193-7. PubMed ID: 25893415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.
    Schlumberger M; Hitzel A; Toubert ME; Corone C; Troalen F; Schlageter MH; Claustrat F; Koscielny S; Taieb D; Toubeau M; Bonichon F; Borson-Chazot F; Leenhardt L; Schvartz C; Dejax C; Brenot-Rossi I; Torlontano M; Tenenbaum F; Bardet S; Bussière F; Girard JJ; Morel O; Schneegans O; Schlienger JL; Prost A; So D; Archambeaud F; Ricard M; Benhamou E
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2487-95. PubMed ID: 17426102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum thyroglobulin in the diagnosis and management of thyroid carcinoma.
    Shlossberg AH; Jacobson JC; Ibbertson HK
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):17-27. PubMed ID: 436303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
    d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
    Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.